Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Gynecologic Oncology|April 1, 1996
Phase 1 trial of intraperitoneal AD-32 in gynecologic malignanciesM Markman, H Homesley, D A Norberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumorsS Goel, A Bulgaru, H Hochster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicinP S Gill, B M Espina, F Muggia, et al.
Gynecologic Oncology|October 31, 2006
Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancerD S Alberts, M Markman, F Muggia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatmentW F Symmans, M D Volm, R L Shapiro, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinicallyP N Lara, D R Gandara, G T Wurz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 1997
Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapyS C Formenti, G Dunnington, B Uzieli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium TrialR J Morgan, T W Synold, D Gandara, et al.
Pageof 6